Home > Financial Ratios > AURO LABORATORIES

AURO LABORATORIES
Core EBITDA Growth

    Back to All Ratios
AURO LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AURO LABORATORIES
Please provide your vote to see the results

AURO LABORATORIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -66.65128.22-6.71-52.3565.67

What is the latest Core EBITDA Growth ratio of AURO LABORATORIES ?

The latest Core EBITDA Growth ratio of AURO LABORATORIES is -66.65 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-66.65
Mar2024128.22
Mar2023-6.71
Mar2022-52.35
Mar202165.67

How is Core EBITDA Growth of AURO LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -66.65
Negative
Mar2024 128.22
Positive
Mar2023 -6.71
Negative
Mar2022 -52.35
Negative
Mar2021 65.67 -

Other Financial Ratios of AURO LABORATORIES


Compare Core EBITDA Growth ratio of peers of AURO LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AURO LABORATORIES ₹150.8 Cr -4.9% 21.7% 17.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,160.0 Cr 1.7% 7.3% 0% Stock Analytics
DIVIS LABORATORIES ₹172,288.0 Cr 1.8% 0.9% 6.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,440.0 Cr 1.3% 4.4% 14.9% Stock Analytics
CIPLA ₹123,149.0 Cr 0.9% -2.9% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,369.0 Cr 0.5% -3.1% 3.3% Stock Analytics


AURO LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AURO LABORATORIES

-4.9%

21.7%

17.4%

SENSEX

0.1%

1.1%

8.4%


You may also like the below Video Courses